Daliresp Dosage
Generic name: roflumilast 500ug
Dosage form: tablet
Drug class: Selective phosphodiesterase-4 inhibitors
Medically reviewed by Drugs.com. Last updated on Mar 3, 2025.
The maintenance dose of DALIRESP is one 500 micrograms (mcg) tablet per day, with or without food.
Starting treatment with a dose of DALIRESP 250 mcg once daily for 4 weeks and increasing to DALIRESP 500 mcg once daily thereafter may reduce the rate of treatment discontinuation in some patients . However, 250 mcg per day is not the effective (therapeutic) dose.
More about Daliresp (roflumilast)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (63)
- Drug images
- Side effects
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Anoro Ellipta
Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
